000 | 01000 a2200301 4500 | ||
---|---|---|---|
005 | 20250512195155.0 | ||
264 | 0 | _c19810413 | |
008 | 198104s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(81)90735-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNalin, D R | |
245 | 0 | 0 |
_aIntraluminal binding of cholera toxin. _h[electronic resource] |
260 |
_bLancet (London, England) _cJan 1981 |
||
300 |
_a153 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 |
_aCharcoal _xtherapeutic use |
650 | 0 | 4 |
_aCholera Toxin _xmetabolism |
650 | 0 | 4 |
_aDiarrhea _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aG(M1) Ganglioside _xtherapeutic use |
650 | 0 | 4 |
_aGangliosides _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntestinal Mucosa _xmetabolism |
650 | 0 | 4 | _aMale |
773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8212 _gp. 153 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(81)90735-2 _zAvailable from publisher's website |
999 |
_c6109916 _d6109916 |